Ernst A et al. |
Lung abcess complicating Legionella micdadei pneumonia in an adult liver transplant recipient: case report and review. |
1998 |
Transplantation |
pmid:9448158
|
Cavaillé-Coll MW and Elashoff MR |
Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation. |
1998 |
Transplantation |
pmid:9448161
|
O'Grady J |
C(2) monitoring: out of the blocks but with some way to go! |
2004 |
Transplantation |
pmid:15201659
|
Fung JJ |
Tacrolimus and transplantation: a decade in review. |
2004 |
Transplantation |
pmid:15201685
|
Busuttil RW and Lake JR |
Role of tacrolimus in the evolution of liver transplantation. |
2004 |
Transplantation |
pmid:15201686
|
Gjertson DW et al. |
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. |
1995 |
Transplantation |
pmid:8545861
|
Andrades KM et al. |
Modulation of Candida albicans virulence by antirejection immunosuppressant drugs. |
2013 |
Transplantation |
pmid:23380869
|
Bunnapradist S et al. |
Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids. |
2003 |
Transplantation |
pmid:12865780
|
Tydén G et al. |
Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantations. |
2007 |
Transplantation |
pmid:17496528
|
Faguer S et al. |
Rituximab therapy for acute humoral rejection after kidney transplantation. |
2007 |
Transplantation |
pmid:17496547
|
Rodrigo E et al. |
Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development. |
2016 |
Transplantation |
pmid:26703349
|
Hashimoto T et al. |
Treatment with FK506 prevents rejection of rat colon allografts. |
1994 |
Transplantation |
pmid:7516586
|
van Hooff JP et al. |
A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. |
2003 |
Transplantation |
pmid:12829890
|
Miroux C et al. |
In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function. |
2012 |
Transplantation |
pmid:22743548
|
Heffron TG et al. |
Pediatric liver transplantation with daclizumab induction. |
2003 |
Transplantation |
pmid:12829908
|
Gonwa T et al. |
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. |
2003 |
Transplantation |
pmid:12829910
|
Gathogo E et al. |
Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients. |
2016 |
Transplantation |
pmid:26413990
|
Andrés A et al. |
A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration. |
2009 |
Transplantation |
pmid:19898206
|
Larsen JL et al. |
Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats. |
2006 |
Transplantation |
pmid:16926589
|
Fisher NC et al. |
Chronic renal failure following liver transplantation: a retrospective analysis. |
1998 |
Transplantation |
pmid:9679823
|
Papadopoulos-Köhn A et al. |
Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant. |
2015 |
Transplantation |
pmid:25208324
|
Ericzon BG et al. |
The effect of FK506 treatment on pancreaticoduodenal allotransplantation in the primate. |
1992 |
Transplantation |
pmid:1376501
|
Gonwa TA et al. |
End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. |
2001 |
Transplantation |
pmid:11773892
|
de Graav GN et al. |
A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation. |
2017 |
Transplantation |
pmid:28403127
|
Fisher RA et al. |
A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. |
1998 |
Transplantation |
pmid:9884248
|
Solez K et al. |
Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9884269
|
Ciancio G et al. |
Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506. |
1997 |
Transplantation |
pmid:9075856
|
Watanabe M et al. |
Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance. |
2013 |
Transplantation |
pmid:23860082
|
Lenaers JI et al. |
Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients. |
2006 |
Transplantation |
pmid:17102764
|
Starzl TE et al. |
Hepatotrophic effects of FK506 in dogs. |
1991 |
Transplantation |
pmid:1702912
|
Yamamoto S et al. |
FK778 and FK506 combination therapy to control acute rejection after rat liver allotransplantation. |
2004 |
Transplantation |
pmid:15591950
|
Tan HP et al. |
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. |
2004 |
Transplantation |
pmid:15591960
|
Nashan B et al. |
Clinical validation studies of Neoral C(2) monitoring: a review. |
2002 |
Transplantation |
pmid:12023607
|
Camirand G et al. |
Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice. |
2001 |
Transplantation |
pmid:11468532
|
Squifflet JP et al. |
Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients. |
2001 |
Transplantation |
pmid:11468536
|
Theruvath TP et al. |
Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. |
2001 |
Transplantation |
pmid:11468538
|
Zervos XA et al. |
Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation. |
1998 |
Transplantation |
pmid:9583863
|
Araki M et al. |
Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. |
2006 |
Transplantation |
pmid:16477217
|
Gallon L et al. |
ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients. |
2006 |
Transplantation |
pmid:16477235
|
Moreau C et al. |
Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient. |
2006 |
Transplantation |
pmid:16477241
|
Niioka T et al. |
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation. |
2012 |
Transplantation |
pmid:23073468
|
Shaffer D et al. |
Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506). |
1995 |
Transplantation |
pmid:7535958
|
Bronster DJ et al. |
Demyelinating sensorimotor polyneuropathy after administration of FK506. |
1995 |
Transplantation |
pmid:7535959
|
Jain A et al. |
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. |
2001 |
Transplantation |
pmid:11374410
|
Swinnen LJ et al. |
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder. |
2008 |
Transplantation |
pmid:18645482
|
Neumann UP et al. |
Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. |
2001 |
Transplantation |
pmid:11374419
|
Chan K et al. |
Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy--an open label, randomized trial. |
2011 |
Transplantation |
pmid:21836540
|
Ahsan N et al. |
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. |
2001 |
Transplantation |
pmid:11477347
|
Andries S et al. |
Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. |
2001 |
Transplantation |
pmid:11477351
|
Wannhoff A et al. |
Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A. |
2014 |
Transplantation |
pmid:25022236
|
Sureshkumar KK and Chopra B |
In search of an optimal induction agent in kidney transplantation. |
2014 |
Transplantation |
pmid:24978038
|
Taler SJ et al. |
Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. |
1996 |
Transplantation |
pmid:8970613
|
Welberry Smith MP and Baker RJ |
The author's reply. |
2014 |
Transplantation |
pmid:24978039
|
Chakrabarti P et al. |
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. |
2000 |
Transplantation |
pmid:11003353
|
Srinivas TR et al. |
The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. |
2005 |
Transplantation |
pmid:16251854
|
Roelen DL et al. |
Differential inhibition of primed alloreactive CTLs in vitro by clinically used concentrations of cyclosporine and FK506. |
1993 |
Transplantation |
pmid:7687397
|
Buell JF et al. |
Malignancy after transplantation. |
2005 |
Transplantation |
pmid:16251858
|
Hougardy JM et al. |
Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure. |
2011 |
Transplantation |
pmid:21192316
|
Yamani MH et al. |
The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. |
2000 |
Transplantation |
pmid:10868634
|
Blakolmer K et al. |
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. |
2000 |
Transplantation |
pmid:10868635
|
Neuhaus P et al. |
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial. |
2000 |
Transplantation |
pmid:10868638
|
Verleden GM et al. |
Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient. |
2002 |
Transplantation |
pmid:12131703
|
Johnson C et al. |
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. |
2000 |
Transplantation |
pmid:10755536
|
Miller J et al. |
Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. |
2000 |
Transplantation |
pmid:10755543
|
Ochiai T et al. |
Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. |
1987 |
Transplantation |
pmid:2447689
|
Mohamed MA et al. |
TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus. |
2000 |
Transplantation |
pmid:10755567
|
Anil Kumar MS et al. |
Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. |
2005 |
Transplantation |
pmid:16210969
|
Inamura N et al. |
Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. |
1988 |
Transplantation |
pmid:2447690
|
van Boekel GA et al. |
Effect of mild diarrhea on tacrolimus exposure. |
2012 |
Transplantation |
pmid:22955188
|
Ellis D et al. |
Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. |
2007 |
Transplantation |
pmid:17589338
|
Webb NJ et al. |
Corticosteroid-free Kidney Transplantation Improves Growth: 2-Year Follow-up of the TWIST Randomized Controlled Trial. |
2015 |
Transplantation |
pmid:25539467
|
Shapiro R et al. |
Tacrolimus in pediatric renal transplantation. |
1996 |
Transplantation |
pmid:8990356
|
Gillard P et al. |
Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy. |
2014 |
Transplantation |
pmid:24770614
|
Przepiorka D et al. |
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus. |
1996 |
Transplantation |
pmid:8990368
|
Brito-Costa A et al. |
Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents. |
2016 |
Transplantation |
pmid:27136260
|
Ko S et al. |
The pharmacokinetic benefits of newly developed liposome-incorporated FK506. |
1994 |
Transplantation |
pmid:7526494
|
Bazerbachi F et al. |
Pancreas-after-kidney versus synchronous pancreas-kidney transplantation: comparison of intermediate-term results. |
2013 |
Transplantation |
pmid:23183776
|
Holländer GA et al. |
Disruption of T cell development and repertoire selection by calcineurin inhibition in vivo. |
1994 |
Transplantation |
pmid:7526495
|
Dieterle CD et al. |
Glucose metabolism after pancreas transplantation: cyclosporine versus tacrolimus. |
2004 |
Transplantation |
pmid:15239622
|
Inomata Y et al. |
The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. |
1996 |
Transplantation |
pmid:8600632
|
Tricot L et al. |
Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. |
2005 |
Transplantation |
pmid:16371923
|
Gruessner RW et al. |
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. |
1996 |
Transplantation |
pmid:8600635
|
Veenhof H et al. |
Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients. |
2017 |
Transplantation |
pmid:27906832
|
Jin L et al. |
Effect of Conversion to CTLA4Ig on Tacrolimus-Induced Diabetic Rats. |
2018 |
Transplantation |
pmid:29319618
|
MacPhee IA and Holt DW |
A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype. |
2008 |
Transplantation |
pmid:18212618
|
Cezário ES et al. |
Gingival overgrowth in renal transplant subjects medicated with tacrolimus in the absence of calcium channel blockers. |
2008 |
Transplantation |
pmid:18212628
|
Rayar M et al. |
High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes. |
2018 |
Transplantation |
pmid:29315140
|
Tourret J et al. |
Immunosuppressive Treatment Alters Secretion of Ileal Antimicrobial Peptides and Gut Microbiota, and Favors Subsequent Colonization by Uropathogenic Escherichia coli. |
2017 |
Transplantation |
pmid:27681266
|
Kuypers DR et al. |
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient. |
2006 |
Transplantation |
pmid:16794545
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Dinçkan A et al. |
Evaluation of the first 100 liver transplantations. |
2008 |
Turk J Gastroenterol |
pmid:18386237
|